Quantcast

Posts related to ‘Seattle Genetics’

Taking An Early Look at 2012 ASCO Biotech/Cancer Stocks (DNDN, LLY, ARIA, ARRY, BVTI, ABPI, CLDX, CYTR, GALE, EXEL, GNBT, GHDX, IMGN, NKTR, NLNK, PCYC, SGEN)

It is now getting close to the middle of May, and that means one thing for biotech investors.  The king of biotech and pharma events is about to take place.  ...
Read Full Story »

Why “Sell the News” on Seattle Genetics (SGEN)

There is an old rule of thumb from biotech investors and traders... SELL FDA APPROVALS.  This is very counter-intuitive on the surface but we wanted to explain in more detail ...
Read Full Story »